Detection of Circulating Tumor DNA in Patients With Uterine Leiomyomas

PURPOSE: The preoperative distinction between uterine leiomyoma (LM) and leiomyosarcoma (LMS) is difficult, which may result in dissemination of an unexpected malignancy during surgery for a presumed benign lesion. An assay based on circulating tumor DNA (ctDNA) could help in the preoperative distin...

Descripción completa

Detalles Bibliográficos
Autores principales: Przybyl, Joanna, Spans, Lien, Lum, Deirdre A., Zhu, Shirley, Vennam, Sujay, Forgó, Erna, Varma, Sushama, Ganjoo, Kristen, Hastie, Trevor, Bowen, Raffick, Debiec-Rychter, Maria, van de Rijn, Matt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105159/
https://www.ncbi.nlm.nih.gov/pubmed/32232185
http://dx.doi.org/10.1200/PO.18.00409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105159/
https://www.ncbi.nlm.nih.gov/pubmed/32232185
http://dx.doi.org/10.1200/PO.18.00409

Ejemplares similares